1559044140.961447132s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +8pQFsV3hI2CxsL8tBNOV4mOMQZcK4bDw#ds001810/derivatives/S03_1D_pre_rejectedtrials_2016-06-15_14-48-04.txt
1559044141.001882419s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +EyeJG1STs.AjfTulDObzgp5UlwHcEtA1#ds001810/derivatives/S03_2B_post_rejectedtrials_2016-06-15_14-44-50.txt
1559044141.043276204s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +pJmOrf1K5puRaQer1yHM2PnbZpOka8t5#ds001810/derivatives/S03_2B_pre_rejectedtrials_2016-06-13_14-53-21.txt
1559044141.078210713s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +BTYlSBC674Dz1qW2EW9A_hk_vxhc6hUi#ds001810/derivatives/S03_2B_pre_rejectedtrials_2016-06-15_14-08-58.txt
1559044141.785621534s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +3qCC5M5koY.vTj.r7sKQ6hJPa2KmIrja#ds001810/derivatives/S04_2D_post_rejectedtrials_2016-07-25_12-24-28.txt
1559044142.240353504s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +DzjKfKLRYNHQtkfgqqgO.WZtw_Qj7xJj#ds001810/derivatives/S04_2D_tDCS_rejectedtrials_2016-07-25_11-47-04.txt
1559044168.573700999s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +ukLSni9HgDlmMIOEDa8KgjQZNavVPzPA#ds001810/derivatives/S24_2D_post_rejectedtrials_2016-07-19_13-40-50.txt
1559044171.509121612s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +IgdvSV82qmSuekLbnnE6BFGVucXDzASa#ds001810/derivatives/S27_2D_post_rejectedtrials_2016-07-22_19-51-01.txt
1559044173.755302149s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +0npQmBxjZ1ZLG5UF38PeAcqFEsA.Dyiy#ds001810/derivatives/S30_1I_pre_rejectedtrials_2016-08-01_21-28-33.txt
1559044174.16685564s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +NtUUZJV0t61SfrDX96xuKAi47_8aRdkf#ds001810/derivatives/S30_2D_post_rejectedtrials_2016-08-02_23-12-10.txt
1559044174.304392123s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +nSuymPmXApeNOwpFuBEp7RyGYT7X2cDt#ds001810/derivatives/S30_2D_pre_rejectedtrials_2016-07-09_14-54-39.txt
1559044178.121720468s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +tcW_EcDr.nG6c95uvaDXTwnsJV0b1RIr#ds001810/derivatives/S33_2I_pre_rejectedtrials_2016-08-04_17-46-31.txt
1559044179.928778621s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +75tvRMSjKr1L1kZF0YfOMR.HcMLfcNON#ds001810/derivatives/S34_2D_pre_rejectedtrials_2016-07-14_14-59-36.txt
1559044181.254993725s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +SN3EKjBAXHKdLYAkujlD7rWImMemJ574#ds001810/derivatives/S35_2I_post_rejectedtrials_2016-08-06_19-35-47.txt
1559044181.914123399s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +RUjuMrhe9JDyadPY2OIZhMRRE6jeHU95#ds001810/derivatives/S36_1I_post_rejectedtrials_2016-08-07_14-27-39.txt
1559044182.444034468s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +5VUEOvNzybcLUBj9iq5DyBoc24oCkrKe#ds001810/derivatives/S36_2D_post_rejectedtrials_2016-08-07_14-52-58.txt
1559044183.036498725s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +yp3JIpUSAhUItUuWAWTT5t6yM9bzaA1L#ds001810/derivatives/S37_1D_post_rejectedtrials_2016-08-07_15-15-41.txt
1559044183.194575616s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +6FNC6K.M61hPnALTrMKVPHuVcQKNIrv3#ds001810/derivatives/S37_1D_pre_rejectedtrials_2016-07-14_17-43-38.txt
1559044184.357759107s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +_.TVZLcPh9Q2C03yAj.5V1qQ_oDs_J.I#ds001810/derivatives/S39_1I_pre_rejectedtrials_2016-08-07_15-45-32.txt
1559044185.333537495s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +.GmbLmNWP_9T46p_Rb5rbLC2KkX2Xb5E#ds001810/derivatives/S40_1D_post_rejectedtrials_2016-08-07_19-35-00.txt
1559044185.47758167s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +r22RNOdjZf0gGlyWGT7VW8J8NisEkJIT#ds001810/derivatives/S40_1D_pre_rejectedtrials_2016-07-14_21-02-02.txt
1559044186.708047162s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +748geC43jC.zgldokaKpzlPTOToGzn41#ds001810/derivatives/S41_1I_pre_rejectedtrials_2016-08-09_18-47-33.txt
1559044187.114231828s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +KRMKUio.Zw09E.jt1pIsLsNeRUSuVtKU#ds001810/derivatives/S41_2D_post_rejectedtrials_2016-08-09_20-02-04.txt
1559044187.254853781s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +QTEMUx3iIQW1xnpPIBbk2RCq1t5dz6zk#ds001810/derivatives/S41_2D_pre_rejectedtrials_2016-07-14_21-13-11.txt
1559044188.286145917s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +jXQgOxfCPCBFVkO1Eho.aX3dY0t67dT0#ds001810/derivatives/S44_2I_post_rejectedtrials_2016-08-10_12-26-24.txt
1559044188.424638632s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +HKR.jMcaEVP5Sk3as7nGjwkkvRUqpN0q#ds001810/derivatives/S44_2I_pre_rejectedtrials_2016-08-09_21-21-30.txt
1559044189.143719198s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +RlJJ7VCkaTysPZzAKEUSOSyryRtuGM4c#ds001810/derivatives/S45_1I_pre_rejectedtrials_2016-08-10_12-31-21.txt
1559044190.261912272s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +AOhN5nhSP3MJ3anackTBGpaq7UPaNGRR#ds001810/derivatives/S47_1I_post_rejectedtrials_2016-08-10_21-36-38.txt
1559044190.417749405s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +3e_G2g_jh_fv5hSD8Bp8yXE_wRY5UzaB#ds001810/derivatives/S47_1I_pre_rejectedtrials_2016-08-10_13-07-47.txt
1559044190.737219089s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +JSq1usPYvtmoFM7AV7Ixu3VEvhXPEB0F#ds001810/derivatives/S47_2D_post_rejectedtrials_2016-08-14_11-28-02.txt
1559044191.353158205s 25607bf8-a3ae-4118-8746-47e358f2ff26:V +UO1uYRUcM680.5Y0KByc8hFj.gDX_Gk.#ds001810/derivatives/S48_1D_post_rejectedtrials_2016-08-14_12-13-14.txt
